surpass cvot tirzepatide vs Dulaglutide for Cardiovascular Outcomes (SURPASS-CVOT) | NEJM SURPASS-CVOT trial: Tirzepatide was non-inferior
Description
Out-of-pocket GLP-1 costs vary widely
Obesity treatment has entered a new era
That paper has just been published
Green detox powder with spirulina, resveratrol & prebiotic fiber
Notably, 77% of adolescents treated with semaglutide achieved at least a 5% reduction in BMI
Premier Aesthetics offers a medical weight loss program designed to assist individuals in losing weight safely and efficiently
